Design, Synthesis, and Biological Evaluation of the First Inhibitors of Oncogenic CHD1LJOURNAL OF MEDICINAL CHEMISTRYIF6.82022-02-2210OA
First-in-Class Inhibitors of Oncogenic CHD1L with Preclinical Activity against Colorectal CancerMOLECULAR CANCER THERAPEUTICSIF5.52020-08-0430OAAI
Drug Design Targeting T-Cell Factor-Driven Epithelial-Mesenchymal Transition as a Therapeutic Strategy for Colorectal CancerJOURNAL OF MEDICINAL CHEMISTRYIF6.82019-11-0114OAAI
Rationally designed BCL6 inhibitors target activated B cell diffuse large B cell lymphomaJOURNAL OF CLINICAL INVESTIGATIONIF13.62016-08-02142OA